[Comment] Increasing walking capacity in patients with peripheral artery disease

The treatment of many patients with peripheral artery disease is not optimal, and indeed is much worse than that in patients with other clinical manifestations of atherosclerotic cardiovascular disease, such as coronary artery disease.1,2 Patients with peripheral artery disease are less likely to receive guideline-recommended therapies, including antiplatelet, lipid-lowering, and other risk-modifying drugs, or to undergo supervised exercise therapy. One reason for this is the lack of awareness of peripheral artery disease and its implications.